# Phase 15 Completion Report

## Result

The v2 release candidate is **GO for isolated release-candidate verification**. Phase 15 was completed without deployment, route activation, traffic cutover, v1 removal, or production research writes.

## Passed gates

- Fresh dependency installation and audit.
- Repository lint, TypeScript builds, v2 package typechecks, and production build.
- Phase 1 architecture tests; Phase 11 web tests; Phase 12 persistence tests; Phase 13 research and Worker tests; Phase 14 analysis, privacy, claim, and exact replay tests.
- Canonical v2 compilation repeated with byte-identical bundle, manifest, and inventory artifacts.
- Reference verification, differential replay, coverage, and report gates.
- Local D1 migration/idempotency, persistence-size, research-payload, web-performance, and analysis-performance checks.
- Chromium, Firefox, and WebKit behavioral/browser coverage (36 passing non-visual cases; WebKit ran in the official Playwright `v1.62.1-noble` container because the Bluefin host lacks Ubuntu ABI names).
- Chromium visual regression, responsive screenshot, and accessibility checks.
- Production writes and empirical-claim eligibility remained disabled.

## Resolved release blockers

1. WebKit host ABI mismatch was resolved by the reproducible `npm run v2:web:test:webkit:container` route using the official Playwright image.
2. The release candidate was verified from a clean commit worktree. Unrelated pre-existing changes remain preserved in the original checkout and are not part of the release commit.

The exact machine-produced blocker list is in `v2/release/release-candidate-receipt.json` and `docs/v2/generated/release-candidate-summary.md`.

## Known legacy suite status

The full repository-wide suite ran with 943 passing tests, 1 skipped, and 5 pre-existing failures in untouched v1 files: one old canonical manifest fingerprint, three legacy Worker compatibility cases, and one primary measurement disclosure case. These remain documented, not hidden.

## Cutover decision

No production cutover is performed by this phase. Keep v1 active and v2 research writes disabled; any future deployment requires separate operational and research-governance approval.
